Aztiq and Innobic conclude acquisition of AEMH for $500m
Through the acquisition, the alliance becomes a key shareholder in Lotus Pharmaceuticals and Adalvo.

Through the acquisition, the alliance becomes a key shareholder in Lotus Pharmaceuticals and Adalvo.
Supported by three prestigious investment companies and the EU's EIF, Eir Ventures is a Nordic-based venture company with €76m to…
ByThank you for subscribing to Pharmaceutical Technology